Zobrazeno 1 - 10
of 46
pro vyhledávání: '"József A. Balog"'
Autor:
József Ágoston Balog, Klaudia Horti-Oravecz, Dorottya Kövesdi, Anikó Bozsik, Janos Papp, Henriett Butz, Attila Patócs, Gábor János Szebeni, Vince Kornél Grolmusz
Publikováno v:
iScience, Vol 27, Iss 6, Pp 109882- (2024)
Summary: Germline pathogenic variants in BRCA1 and BRCA2 (gpath(BRCA1/2)) represent genetic susceptibility for hereditary breast and ovarian cancer syndrome. Tumor-immune interactions are key contributors to breast cancer pathogenesis. Although earli
Externí odkaz:
https://doaj.org/article/c08dc478435c457c8941859c873d1b9a
Autor:
József Á. Balog, Ágnes Zvara, Vivien Bukovinszki, László G. Puskás, Attila Balog, Gábor J. Szebeni
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionSystemic autoimmune diseases (SADs) are a significant burden on the healthcare system. Understanding the complexity of the peripheral immunophenotype in SADs may facilitate the differential diagnosis and identification of potential therap
Externí odkaz:
https://doaj.org/article/4e9b4c43adb14a7c9108e826395475da
Autor:
Nikolett Gémes, József Á. Balog, Patrícia Neuperger, Erzsébet Schlegl, Imre Barta, János Fillinger, Balázs Antus, Ágnes Zvara, Zoltán Hegedűs, Zsolt Czimmerer, Máté Manczinger, Gergő Mihály Balogh, József Tóvári, László G. Puskás, Gábor J. Szebeni
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTobacco smoking generates airway inflammation in chronic obstructive pulmonary disease (COPD), and its involvement in the development of lung cancer is still among the leading causes of early death. Therefore, we aimed to have a better un
Externí odkaz:
https://doaj.org/article/59d1e13b34fc423cb0f8e6ed54c43031
Autor:
Patrícia Neuperger, Klára Szalontai, Nikolett Gémes, József Á. Balog, László Tiszlavicz, József Furák, György Lázár, László G. Puskás, Gábor J. Szebeni
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe effect of platinum-based chemotherapy (Chem.) and second- or multiple- line immune checkpoint PD-1 blocking therapy by Nivolumab or Pembrolizumab (ICI) was assayed in the peripheral blood of non-small cell lung cancer (NSCLC) patients
Externí odkaz:
https://doaj.org/article/f514d9e1f3a44074afa95d41b6bf325d
Autor:
Enikő Szabó, Szabolcs Modok, Benedek Rónaszéki, Anna Faragó, Nikolett Gémes, Lajos I. Nagy, László Hackler, Katalin Farkas, Patrícia Neuperger, József Á. Balog, Attila Balog, László G. Puskás, Gabor J. Szebeni
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundVaccination has proven the potential to control the COVID-19 pandemic worldwide. Although recent evidence suggests a poor humoral response against SARS-CoV-2 in vaccinated hematological disease (HD) patients, data on vaccination in these pa
Externí odkaz:
https://doaj.org/article/70d9f571fefd4dca894e4d98dc1c9c62
Autor:
Gábor J. Szebeni, Róbert Alföldi, Lajos I. Nagy, Patrícia Neuperger, Nikolett Gémes, József Á. Balog, László Tiszlavicz, László G. Puskás
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1254 (2023)
The advent of immunotherapy has revolutionized cancer treatments. However, the application of immune checkpoint inhibitors may entail severe side effects, with the risk of therapeutic resistance. The generation of chimeric antigen receptor (CAR) T-ce
Externí odkaz:
https://doaj.org/article/f75a057661764112b2285f31223e7e2d
Autor:
József Á. Balog, Viktor Honti, Éva Kurucz, Beáta Kari, László G. Puskás, István Andó, Gábor J. Szebeni
Publikováno v:
Genomics, Proteomics & Bioinformatics, Vol 19, Iss 2, Pp 243-252 (2021)
Single-cell mass cytometry (SCMC) combines features of traditional flow cytometry (i.e., fluorescence-activated cell sorting) with mass spectrometry, making it possible to measure several parameters at the single-cell level for a complex analysis of
Externí odkaz:
https://doaj.org/article/2f35895df97a478785d51810ab4becff
Autor:
Gábor J. Szebeni, Nikolett Gémes, Dániel Honfi, Enikő Szabó, Patrícia Neuperger, József Á. Balog, Lajos I. Nagy, Zoltán Szekanecz, László G. Puskás, Gergely Toldi, Attila Balog
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundVaccine-induced immunity is essential for controlling the COVID-19 pandemic. Data on humoral and cellular immunogenicity and safety of different SARS-CoV-2 vaccines in patients with autoimmune rheumatic and musculoskeletal diseases (RMDs) a
Externí odkaz:
https://doaj.org/article/19da92fcde764539a810a447695aa21a
Autor:
Dániel Honfi, Nikolett Gémes, Enikő Szabó, Patrícia Neuperger, József Á. Balog, Lajos I. Nagy, Gergely Toldi, László G. Puskás, Gábor J. Szebeni, Attila Balog
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 19, p 11411 (2022)
Vaccination against SARS-CoV-2 to prevent COVID-19 is highly recommended for immunocompromised patients with autoimmune rheumatic and musculoskeletal diseases (aiRMDs). Little is known about the effect of booster vaccination or infection followed by
Externí odkaz:
https://doaj.org/article/ed57285578d84a448c42a903cf627bde
Publikováno v:
BioTechniques, Vol 63, Iss 6, Pp 261-266 (2017)
Synthetic DNA has been used as an authentication code for a diverse number of applications. However, existing decoding approaches are based on either DNA sequencing or the determination of DNA length variations. Here, we present a simple alternative
Externí odkaz:
https://doaj.org/article/489727ce39f14684b4abac73bbeee321